Edition:
United States

Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)

600196.SS on Shanghai Stock Exchange

42.88CNY
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
¥42.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
16,802,198
52-wk High
¥45.50
52-wk Low
¥22.29

Latest Key Developments (Source: Significant Developments)

Shanghai Fosun Pharmaceutical Group unit signs cooperate agreement for senile disease special hospital
Monday, 11 Dec 2017 09:12am EST 

Dec 11 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> ::Says its controlling unit signed cooperate agreement with a Zigong local hospital to set up a senile disease special hospital.  Full Article

Shanghai Fosun Pharmaceutical Group unit signs strategic cooperation framework agreement with government
Wednesday, 29 Nov 2017 05:53am EST 

Nov 29(Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says co's unit Shanghai Henlius Biotech signed strategic cooperation framework agreement with local government of Songjiang District, Shanghai City.Says unit plans to set up biological medicine firm and biological medicine industrialization base in Songjiang District, Shanghai City.  Full Article

Shanghai Fosun Pharmaceutical Group unit receives approval for drug clinical trials
Monday, 13 Nov 2017 07:13am EST 

Nov 13 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says Taiwan-based unit received drug clinical trials approval in Taiwan, for its injection named HLX06 .  Full Article

Fosun Pharma's unit in deal to buy hospital for 909 mln yuan
Sunday, 12 Nov 2017 09:12am EST 

Nov 12 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK:Says unit signs agreement to buy 60 percent stake in Shenzhen-based hospital for 909 million yuan ($136.90 million).  Full Article

Shanghai Fosun Pharma Group unit receives GMP certificate
Wednesday, 8 Nov 2017 02:47am EST 

Nov 8 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> ::* Says its controlling unit received goods manufacture practice (GMP) certificate from Liaoning Food and Drug Administration .* Certificate issued small volume injection (non final sterilization), freeze-dried powder injection, hard capsule manufactured by the unit and the valid period is until Nov. 2, 2022.  Full Article

Shanghai Fosun Pharmaceutical (Group) unit gets approval for drug clinical trial from FDA
Monday, 30 Oct 2017 04:59am EDT 

Oct 30 (Reuters) - Shanghai Fosun Pharmaceutical (Group) Co Ltd <600196.SS> ::Says its unit gets approval for drug (FN-1501) clinical trial from FDA.  Full Article

Shanghai Fosun Pharma's unit signs agreement to buy France's Tridem Pharma
Sunday, 29 Oct 2017 06:24am EDT 

Oct 29 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK:Says unit signs agreement to buy France's firm Tridem Pharma for up to 63 million euros ($73.13 million).  Full Article

Shanghai Fosun Pharmaceutical Group unit receives GMP certificate
Tuesday, 26 Sep 2017 07:19am EDT 

Sept 26(Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says co's Shenyang-based unit received goods manufacture practice (GMP) certificate from Liaoning Food and Drug Administration, regarding tablet and hard capsule.Says valid period is until Sept. 17, 2022.  Full Article

Shanghai Fosun Pharmaceutical Group unit receives GMP certificate
Monday, 25 Sep 2017 11:54pm EDT 

Sept 26(Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> ::* Says its unit received goods manufacture practice (GMP) certificate from Hubei Food and Drug Administration.* Says certificate issued to arginine phosphokinase and histidine hydrochloride manufactured by the company and the valid period is until Sept. 17, 2022.  Full Article

Shanghai Fosun Pharmaceutical Group unit signs investment cooperation framework agreement with hospital
Monday, 25 Sep 2017 05:23am EDT 

Sept 25(Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says co's unit signs investment cooperation framework agreement with a Mianyang-based hospital .Says two entities will work together to change a branch of the hospital to a women's and children's hospital and will jointly set up a JV for construction, management and operation of the women's and children's hospital.Says unit will hold 80 percent stake in the JV.  Full Article